Teves, Alrenze .
HRN: 13-26-88 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2022
CO-AMOXICLAV 625MG (TAB)
05/22/2022
05/29/2022
PO
625
BID
Lacerated Wound
Waiting Final Action